These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8858758)

  • 1. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Muscle relaxants in the ICU].
    Schneider G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applied pharmacology of common neuromuscular blocking agents in critical care.
    Prielipp RC; Coursin DB
    New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.
    Clarens DM; Kelly KJ; Gilliland SS; Kohls PK; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent paralysis in critically ill patients after the use of neuromuscular blocking agents.
    Hoyt JW
    New Horiz; 1994 Feb; 2(1):48-55. PubMed ID: 7922429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care.
    Armstrong DK; Crisp CB
    New Horiz; 1994 Feb; 2(1):85-93. PubMed ID: 7922434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of practice guidelines on prescribing patterns of nondepolarizing neuromuscular blocking agents.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1996; 16(5):899-904. PubMed ID: 8888085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
    Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children.
    Johnson PN; Miller J; Gormley AK
    Pharmacotherapy; 2011 Jun; 31(6):609-20. PubMed ID: 21923445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolonged paralysis after long-term administration of vecuronium in the intensive care unit].
    Tanaka O; Akai H; Takekida S; Tanaka Y; Wake M; Iijima K; Horikawa Y; Ijichi K
    Masui; 2006 Aug; 55(8):992-4. PubMed ID: 16910480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of muscle relaxants in the intensive care unit.
    Sharpe MD
    Can J Anaesth; 1992 Nov; 39(9):949-62. PubMed ID: 1451224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cisatracurium in critical care: a review of the literature.
    Szakmany T; Woodhouse T
    Minerva Anestesiol; 2015 Apr; 81(4):450-60. PubMed ID: 24721895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blocking agents and sedative drugs. Clinical uses and toxic effects in the critical care unit.
    Durbin CG
    Crit Care Clin; 1991 Jul; 7(3):489-506. PubMed ID: 1863878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical illness neuropathies].
    Magistris MR
    Rev Neurol (Paris); 2002 Mar; 158(3):293-9. PubMed ID: 11976588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room.
    Loughlin KA; Weingarten CM; Nagelhout J; Stevenson JG
    Pharmacotherapy; 1996; 16(5):942-50. PubMed ID: 8888091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vecuronium.
    Dimens Crit Care Nurs; 1999; 18(5):23. PubMed ID: 10640038
    [No Abstract]   [Full Text] [Related]  

  • 19. Have we learned how to relax our patients, by thinking outside the box?
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532
    [No Abstract]   [Full Text] [Related]  

  • 20. Complications associated with sedative and neuromuscular blocking drugs in critically ill patients.
    Prielipp RC; Coursin DB; Wood KE; Murray MJ
    Crit Care Clin; 1995 Oct; 11(4):983-1003. PubMed ID: 8535989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.